PresentationPresentation The Role of P21-Activated Kinase 4(PAK4) in Cancer Stemness & Epithelial-to-Mesenchymal Transition PDF (752.93 KB) Read MorePresentation KPT-9274 Inhibits Cellular NAD and Synergies with NAD Depleting Enzymes to Induce Cancer Cell Death PDF (874.72 KB) Read MorePresentation Selinexor, a Selective Inhibitor of Nuclear Export (SINE) Compound, Inhibits NF-κBActivity by Sequestering IκB-α in the Nucleus and Blocking IκB-α Degradation PDF (221.72 KB) Read MorePresentation In Vivo Efficacy of PAK4 Allosteric Modulator, KPT-9274, against a triple negative breast cancer model PDF (851.05 KB) Read MorePresentation Selective Inhibitor of Nuclear Export (SINE) compounds prevent migration and proliferation of Triple Negative Breast Cancer (TNBC) cells by restoring expression of ARRDC3 PDF (1.72 MB) Read MorePresentation Synergistic Antitumor Effect of Selinexor, a Selective Inhibitor of Nuclear Export (SINE) Compound and Trastuzumab in a Mouse Model of Breast Cancer PDF (1.07 MB) Read MorePresentation Selinexor, a Selective Inhibitor of Nuclear Export (SINE) Compound, Shows Synergistic Anti-tumor Activity when Combined with PD-1 Blockade in a Mouse Model of Colon Cancer PDF (1.22 MB) Read MorePresentation Synergistic Antitumor Effect of Selinexor, a Selective Inhibitor of Nuclear Export (SINE) Compound and Panobinostat in a Mouse Model of Multiple Myeloma PDF (1.08 MB) Read MorePresentation Selinexor, a Selective Inhibitor of Nuclear Export (SINE) Compound Shows Enhanced Anti-tumor Activity When Combined with Either Venetoclax or Bendamustine in Diffuse Large B Cell Lymphoma (DLBCL) Mouse Models PDF (1.11 MB) Read MorePresentation KPT-8602 is a second-generation XPO1 inhibitor with improved in vivo tolerability that demonstrates potent acute lymphoblastic leukemia activity PDF (1.35 MB) Read More Previous 1 … 5 6 7 8 9 … 15 Next